Post Heart Transplant Abandoned Lead Fragments: How to Avoid It?

Hakmi, Samer; Pecha, Simon; Bernhardt, A.; Deuse, T.; Barten, M.; Wagner, Franziska; Reichenspurner, H.

doi:10.1016/j.healun.2016.01.814

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 Heart transplantation is an accepted treatment option for stage D heart failure, and more than 4000 heart transplants are performed each year worldwide. [3][4][5][6][7][8] The purpose of our study was to evaluate the prevalence of retained CIED fragments in patients undergoing heart transplantation at our institution, and to identify risk factors and associated complications. Nevertheless, sometimes complete extraction is not possible and ICD coils or lead fragments are left behind.…”

Section: Introductionmentioning

confidence: 99%

“…[3][4][5][6][7][8] The purpose of our study was to evaluate the prevalence of retained CIED fragments in patients undergoing heart transplantation at our institution, and to identify risk factors and associated complications. 1 Heart transplantation is an accepted treatment option for stage D heart failure, and more than 4000 heart transplants are performed each year worldwide.…”

mentioning

confidence: 99%

“…Nevertheless, sometimes complete extraction is not possible and ICD coils or lead fragments are left behind. [3][4][5][6][7][8] The purpose of our study was to evaluate the prevalence of retained CIED fragments in patients undergoing heart transplantation at our institution, and to identify risk factors and associated complications.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Burden and consequences of retained cardiovascular implantable electronic device lead fragments after heart transplantation

Álvarez

Sperry

Pérez

et al. 2018

American Journal of Transplantation

View full text Add to dashboard Cite

We performed a retrospective review of 402 consecutive patients who underwent heart transplantation at our institution between January 2009 and March 2017. A retained cardiovascular implantable electronic device (CIED) fragment was identified after transplantation in 49 of the 301 patients (16.2%) with CIED at baseline. Patients with retained fragments had leads with longer dwell times (median 2596 [1982, 3389] vs 1384 [610, 2202] days, P < .001), higher prevalence of previously abandoned leads (14.3% vs 2.8%, P = .003), and dual-coil defibrillator leads (98% vs 81%, P = .001) compared with patients without retained fragments. Five patients (10%) with retained CIED fragments underwent magnetic resonance imaging without adverse events. There was no difference in overall mortality between patients with and without CIED fragments (12% vs 11%, P = .81) Patients with retained fragments located in the superior vena cava had significantly higher fluoroscopic times (3.3 vs 2.9 minutes, P = .024) during subsequent endomyocardial biopsies. In a competing risk analysis, presence of a retained CIED fragment was associated with upper extremity deep venous thrombosis (sub hazard ratio [HR] 2.19, 95% confidence interval [CI] 1.17-4.10, P = .014) but not bloodstream infection after adjusting for potential confounders. In summary, retained CIED fragments are common after heart transplantation, and are associated with longer radiation exposure during biopsy procedures and upper extremity deep venous thrombosis.

show abstract